APA (7th ed.) Citation

SW, K., M, G., R, A., F, H., & M, K. (2012). Treatment of B cell lymphoma with chemotherapy plus rituximab: A survival benefit can be demonstrated in the routine data of a regional cancer registry. Annals of Hematology, 91(4), 561.

Chicago Style (17th ed.) Citation

SW, Krause, Gerken M, Andreesen R, Hofstädter F, and Klinkhammer-Schalke M. "Treatment of B Cell Lymphoma with Chemotherapy Plus Rituximab: A Survival Benefit Can Be Demonstrated in the Routine Data of a Regional Cancer Registry." Annals of Hematology 91, no. 4 (2012): 561.

MLA (9th ed.) Citation

SW, Krause, et al. "Treatment of B Cell Lymphoma with Chemotherapy Plus Rituximab: A Survival Benefit Can Be Demonstrated in the Routine Data of a Regional Cancer Registry." Annals of Hematology, vol. 91, no. 4, 2012, p. 561.